Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_assertion type Assertion NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_head.
- NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_assertion description "[HER2 overexpression was found in only four cases (10.5%) of the studied primary tumors and in all cases the HER2 expression was retained in the paired metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_provenance.
- NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_assertion evidence source_evidence_literature NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_provenance.
- NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_assertion SIO_000772 18172732 NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_provenance.
- NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_assertion wasDerivedFrom lhgdn-20090331 NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_provenance.
- NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_assertion wasGeneratedBy ECO_0000203 NP111337.RABgU0tjoSbxIc8WZQwK18-MvfMYtaIQKbSbdbbdr46Lk130_provenance.